ForesightTM ICE

Collaboration. Navigation. Innovation.

Early results from clinical study

Southlake Regional Health Centre is the leading Canadian research site for the first phase of the Foresight ICE trial.

Read More

“The Foresight ICE has provided us a new option for guiding trans-septal puncture and I see potential in the 3D imaging that we will be able to take advantage of in several EP and structural cases.”

Dr. Atul Verma
Director Arrhythmia Services
Southlake Regional Health Centre

Product News

Conavi Medical Announces 510(k) Clearance

In 2015, we’re happy to announce that Conavi receives 510(k) clearance for their 3D Foresight ICE System™.

Foresight ICE System™

Our Foresight ICE System™ gives users  new features: Forward looking and 3D intracardiac ultrasound capabilities.

Play Medical Animation

Company News

Conavi Welcomes New CEO

Conavi is pleased to announce that Murray Maynard has been appointed the Chief Executive Officer of the company, effective July 4th, 2016. Mr. Maynard has extensive experience in the cardiovascular device field, including sales, marketing, distribution, manufacturing, finance and board-level roles with several devices companies.

Learn more

Early Results from Study

The Foresight ICE System, developed out of Sunnybrook Research Institute, is the focus of Southlake Regional Health Centre’s first phase of the Foresight ICE study. This study is looking at the first clinical use and efficacy of 2D forward and 3D intracardiac echocardiography to guide trans-septal punctures during AF ablation procedures. Several patients have already had successful trans-septal puncture supported by the use of the Foresight ICE system.

Learn more about the study

We have a new name

We have a new name, and a new look – Colibri Technologies is now Conavi Medical.

Read a letter from our co-founders

It's clear that there's a need. We have a path to get there.

Dr. Brian Courtney